Tag: Liver Disease: Misc.
~10 Percent of Psoriasis Patients Have High Risk for Liver Fibrosis
Increased odds ratios seen for advanced liver fibrosis with age older than 50 years, BMI >30, diabetes, hypertension, dyslipidemia, metabolic syndrome
Bariatric Surgery Cuts CVD Risk in Patients With Obesity, NAFLD
Findings seen versus nonsurgical care among individuals with severe obesity and nonalcoholic fatty liver disease
Risk for Advanced Fibrosis Examined for Relatives of NAFLD Patients
Age 50 years or older, male sex, diabetes mellitus, first-degree relative with NAFLD with advanced fibrosis predict advanced fibrosis
Use of Living-Donor Liver Transplantation Low in U.S., U.K., Canada
One-, five-, 10-year patient survival was 92.6, 82.8, 70.0 percent in United States; 96.1, 89.9, and 82.2 percent in Canada
Prenatal Exposure to Endocrine-Disrupting Chemicals Linked to Liver Injury
Odds of liver injury in childhood increased with prenatal exposure to organochlorine pesticides, PBDEs, perfluoroalkyl substances, and metals
Sleep Tied to Metabolic Dysfunction-Associated Fatty Liver Disease
Highest risk for MAFLD was seen for those with disturbance in nighttime sleep and prolonged daytime napping
NAFLD Linked to Increased Risk for Dementia in Seniors
Greater risk for dementia conferred by comorbid nonalcoholic fatty liver disease and heart disease or stroke
113-Gene Signature May Predict Long-Term HCC Risk in NAFLD
Prognostic liver signature validated in cohorts of patients with NAFLD, with and without history of hepatocellular carcinoma
COVID-19 Tied to Progression of Chronic Liver Disease
About one in five patients with preexisting chronic liver disease develop progressive cholestasis after severe COVID-19
Risk for Existing, Incident T2D High in Children With NAFLD
Risk factors for incident T2D include female gender, BMI z-score, and more severe liver histology, including steatosis grade, fibrosis stage
